Home/ Supplements/ Vitamin K/ Triple Strength Vitamin K-2 150 mcg Mena...

Triple Strength Vitamin K-2 150 mcg Menaquinine-7

product on market Capsule Solaray Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 as menaquinone-7 is researched for its role in supporting bone health and cardiovascular function by regulating calcium distribution. There is moderate evidence suggesting it helps prevent arterial calcification and improves bone mineral density. The ingredient profile is generally considered safe for most users.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Triple Strength Vitamin K-2 150 mcg Menaquinine-7
Open Full PDF View on NIH DSLD →
Details

Label Data

1 VegCap(s)
Serving Size
30
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

150 mcg (125% DV)
1.2× RDA — within safe limits 275 studies (A:9, B:175)

Other Ingredients

Cellulose Cellulose Glycerol Monostearate Magnesium Stearate fermented defatted Chickpea flour extract Silica
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Use only as directed. Take 1 VegCap twice daily with a meal or glass of water.

Warnings & Precautions

Warning: Do not use if safety seal is broken or missing. Keep your licensed health care practitioner informed when using this product.

Keep out of reach of children.

Formulation Notes

Bone support Cardiovascular support Vascular support

Vegan

Discussion: The premium Vitamin K-2 menaquinone-7 used in this formula is derived from chickpea. Menaquinone-7 (MK-7) is known to enjoy a longer half-life than other forms of Vitamin K, and is therefore believed to offer unique benefits to the body. It is intended to support cardiovascular health, bone formation and vascular health.

Additional Information

Lab Verified Vegan

Since 1973, we've scoured the globe for the highest quality ingredients, connecting you with the most efficacious supplements that help you live brighter & embrace the moments that matter most.

Store in a cool, dry place.

100% PCR Bottles

Metadata

Product Details

UPC / SKU0 76280 27877 4
DSLD Entry Date2025-03-25
Product TypeVitamin
FormCapsule
BrandSolaray
DSLD ID326138
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

Vitamin D Synergy with Vitamin K1
Designs for Health · Capsule
100
Vitamin D Synergy with Vitamin K1
Designs for Health · Capsule
100
Natural Vitamin K2 45 mcg
Doctor's Best · Capsule
100
K 100 mcg
Thompson · Capsule
100
Vitamin K2 300 mcg MK-7
Innerzyme · Capsule
100
View all Vitamin K products →
Vitamin K research Best Vitamin K All Vitamin K products More from Solaray View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.